Figure 15.
(a) Two-dimensional diagram showing the interaction between Sorafenib and the VEGFR-2 active site. (b) 3D protein–ligand interactions between Sorafenib and the VEGFR-2 active site.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.